Literature DB >> 21649531

Prevalence and correlates of echocardiographic left atrial enlargement in hypertensive outpatients in clinical practice.

Cesare Cuspidi1, Francesca Negri, Laura Lonati, Maria Lorenza Muiesan, Anna Capra, Alberto Milan, Carla Sala, Gian Battista Danzi, Marcella Longo, Alberto Morganti.   

Abstract

Prevalence of left atrial enlargement (LAE) in hypertension has been mostly assessed in population-based samples and selected hypertensive groups. A few data are available in clinical practice. We examined LAE prevalence and severity in a cohort of hypertensive patients referred by general practitioners to a routine echocardiographic examination. A total of 2170 hypertensive individuals (mean age 62 years, 53% men) referred by practitioners to 17 outpatient echocardiographic laboratories across Italy for detection of hypertensive cardiac disease were included in the study. LAE was defined as: A) absolute LA diameter >4.0 cm in men and >3.8 cm in women; B) LA diameter normalized to body surface area (BSA) >2.3 cm/m(2) in both sexes. Left atrial enlargement was graded as mild, moderate, and severe according to Lang's report. Patients with LAE were 38% by criterion A, and 20% by criterion B. A moderate/severe increase in LA size was present in 34% (A) and 32% (B) of patients with LAE. Severe LAE was 3.3-fold (A) and 2.6-fold (B) more frequent in women than in men. Left ventricular mass was the strongest correlate of absolute LA diameter as well as of normalized LA diameter, after age. Left atrial enlargement defined either by absolute or normalized LA diameter is a frequent cardiac phenotype in hypertensive patients referred to echo-labs in clinical practice. This cardiac parameter is closely related to LV mass and its severity is highly prevalent in women.

Entities:  

Mesh:

Year:  2011        PMID: 21649531     DOI: 10.3109/10641963.2010.549265

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  8 in total

1.  Left atrial enlargement and blood pressure variability in untreated hypertensive patients.

Authors:  Naoki Nakagawa; Naoyuki Hasebe
Journal:  Hypertens Res       Date:  2016-05-19       Impact factor: 3.872

Review 2.  Sex, gender, and subclinical hypertensiveorgan damage-heart.

Authors:  Cesare Cuspidi; Elisa Gherbesi; Carla Sala; Marijana Tadic
Journal:  J Hum Hypertens       Date:  2022-08-27       Impact factor: 2.877

3.  Evaluation of left atrial function in hypertensive patients with and without left ventricular hypertrophy using velocity vector imaging.

Authors:  Li Yang; Qiong Qiu; Si-hua Fang
Journal:  Int J Cardiovasc Imaging       Date:  2014-07-09       Impact factor: 2.357

4.  Left atrial dimension is related to blood pressure variability in newly diagnosed untreated hypertensive patients.

Authors:  Franco Cipollini; Enrica Arcangeli; Giuseppe Seghieri
Journal:  Hypertens Res       Date:  2016-03-24       Impact factor: 3.872

5.  Correlation between CH2DS2-VASc Score and Serum Leptin Levels in Cardioembolic Stroke Patients: The Impact of Metabolic Syndrome.

Authors:  Anna Szczepańska-Szerej; Jacek Kurzepa; Aneta Grabarska; Joanna Bielewicz; Ewa Wlizło-Dyś; Konrad Rejdak
Journal:  Int J Endocrinol       Date:  2017-10-31       Impact factor: 3.257

6.  Left atrial enlargement in the early stage of hypertensive heart disease: a common but ignored condition.

Authors:  Guanhua Su; Heng Cao; Sudan Xu; Yongxin Lu; Xinxin Shuai; Yufei Sun; Yuhua Liao; Jingdong Li
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-02-20       Impact factor: 3.738

7.  Prevalence of left atrial enlargement and its risk factors in general Chinese population.

Authors:  Qiaoyun Ou; Yintao Chen; Shasha Yu; Xiaofan Guo; Huijie Zhao; Yingxian Sun
Journal:  BMC Cardiovasc Disord       Date:  2016-03-05       Impact factor: 2.298

8.  The relation between blood pressure components and left atrial volume in the context of left ventricular mass index.

Authors:  Marta Rojek; Marek Rajzer; Wiktoria Wojciechowska; Jerzy Gąsowski; Tomasz Pizoń; Danuta Czarnecka
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.